Anti-egfr/anti-c-met Bispecific Antibody Emb-01
Anti-egfr/anti-c-met Bispecific Antibody Emb-01 Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-egfr/anti-c-met Bispecific Antibody Emb-01 is under investigation in clinical trial NCT03797391 (A Dose Escalation Study of Anti-egfr/anti-c-met Bispecific Antibody Emb-01 in Participants With Advanced/metastatic Solid Tumors).
Trade Name | Anti-egfr/anti-c-met Bispecific Antibody Emb-01 |
Generic | EMB-01 |
EMB-01 Other Names | Anti-egfr/anti-c-met bispecific antibody emb-01, Anti-egfr/c-met bispecific antibody emb-01 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-egfr/anti-c-met Bispecific Antibody Emb-01